AMENDMENT NO. 1 TO ROLLOVER AGREEMENT
Exhibit 10.34
EXECUTION COPY
AMENDMENT NO. 1 TO ROLLOVER AGREEMENT
AMENDMENT NO. 1 TO ROLLOVER AGREEMENT (this “Amendment”) dated as of September 23, 2003, by and between Pharma Services Holding, Inc., a Delaware corporation (the “Company”), Xxxxxx X. Xxxxxxxx, Ph.D. (“DG”), an individual, Xxxx X. Xxxxxxxx, an individual, Xxxxx Xxxxxx Xxxxxxxx, an individual, the Xxxxxxxx Family Foundation, a North Carolina private foundation, the Xxxxxxxx Family Limited Partnership, a North Carolina limited partnership, and the GFEF Limited Partnership, a North Carolina limited partnership (each, including DG, an “Investor” and, collectively, the “Investors”). Capitalized terms used herein but not defined herein shall have the meanings ascribed to them in that certain Rollover Agreement, dated as of August 28, 2003, by and among the Company and the Investors (the “Rollover Agreement”).
WHEREAS, as of August 28, 2003, the Company and Investors entered into the Rollover Agreement, which provided, among other things, for the contribution of Rollover Shares and Company Options to the Company immediately prior to the consummation of the Merger in exchange for Unit Shares, in the amounts set forth on Annex I thereto; and
WHEREAS, the Company and Investors desire to change the amount of Rollover Shares and Company Options being contributed by the Investors to the Company at the Closing; and
WHEREAS, in order to effectuate such changes the Company and the Investors desire to amend certain provisions of the Rollover Agreement, all in accordance with Section 11(h) thereof.
NOW, THEREFORE, in consideration of the mutual covenants and agreements and the representations and warranties herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
1. Preamble. The second WHEREAS clause of the Rollover Agreement shall be deleted in its entirety and replaced with the following:
“WHEREAS, DG owns 161,531 shares of Quintiles Common Stock (the “DG XXX Shares”) which are held through the Quintiles Transnational Corp. Employee Stock Ownership and 401(k) Plan (the “Company ESOP”); and”
2. Share Ownership. The last two sentences of Section 4(a) of the Rollover Agreement shall be deleted in their entirety and replaced with the following:
“Except for DG who owns 181,679 shares of Quintiles Common Stock which are not being contributed to the Company hereunder and which are not being surrendered to the
Company as consideration for the Unit Shares (the “Retained Securities”), such Investor does not have record or beneficial ownership (as determined pursuant to Rule 13d-3 under the Exchange Act) of any (i) shares of Quintiles Common Stock except for the Rollover Shares and (ii) of any options in Quintiles except for the Company Options. Except for the Rollover Shares, the Company Options and the Retained Securities, neither such Investor nor any Affiliate of such Investor has any equity or similar interest in Quintiles or any Subsidiary of Quintiles.”
3. Annex I. Annex I of the Rollover Agreement shall be deleted in its entirety and replaced with the revised Annex I attached to this Amendment.
4. Ratification of Other Provisions. Except as expressly modified hereby, the Rollover Agreement shall remain in full force and effect and is hereby ratified and confirmed.
[Signature Page to Follow]
IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by each Investor and by a duly authorized officer of the Company as of the date and year first above written.
PHARMA SERVICES HOLDING, INC. | ||
By: | /s/ Xxxxxx X. Xxxxxxxx | |
Name: | ||
Title: |
/s/ Xxxxxx X. Xxxxxxxx |
Xxxxxx X. Xxxxxxxx, Ph.D. |
Annex I
Investor |
Rollover Shares * |
Company Options |
Shares of Common Stock |
Shares of Series A Preferred Stock * |
||||||||||||
Xx. Xxxxxx X. Xxxxxxxx (excluding the DG XXX Shares) |
5,567,705 | 2,018,691 | 17,012,569.8318 | 78,805.6260 | ||||||||||||
Xx. Xxxxxx X. Xxxxxxxx (DG XXX Shares) |
161,531 | 0 | 480,352.6456 | 2,225.0895 | ||||||||||||
Xxxx X. Xxxxxxxx (excluding the JHG XXX Shares) |
258,078 | 0 | 767,459.1879 | 3,555.0245 | ||||||||||||
Xxxx X. Xxxxxxxx (JHG XXX Shares) |
1,200 | 0 | 3,568.4988 | 16.5300 | ||||||||||||
Xxxxx Xxxxxx Xxxxxxxx |
13,343 | 0 | 39,678.7326 | 183.7998 | ||||||||||||
The Xxxxxxxx Family Foundation |
55,000 | 0 | 163,556.1936 | 757.6250 | ||||||||||||
Xxxxxxxx Family Limited Partnership |
240,000 | 0 | 713,699.7539 | 3,306.0000 | ||||||||||||
GFEF Limited Partnership |
14,200 | 0 | 42,227.2354 | 195.6050 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
TOTAL |
6,311,057 | 2,018,691 | 19,223,112.0796 | 89,045.2998 | ||||||||||||
|
|
|
|
|
|
|
|
(*) | Subject to appropriate pro rata reduction in the event debt securities are issued by Intermediate Subsidiary at or prior to the Effective Time; provided, that DG may then elect which of the Investors’ Rollover Shares will not be contributed to the Company in order to accomplish such pro rata reduction. |